Stockscreener 앱 받기
10.74
0.85%
0.09
시장 영업 전:
10.75
0.010
+0.09%
Adma Biologics Inc 주식(ADMA)의 최신 뉴스
Does ADMA Biologics' Growth Story Outweigh Short-Seller Concerns? - Zacks Investment Research
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc.ADMA - PR Newswire
bioAffinity Stock Surges 113.8% in 3 Months: What's Driving the Rally? - TradingView — Track All Markets
ADMA Investor Alert: ADMA Biologics Securities Fraud InvestigationInvestors With Losses May ... - Caledonian Record
ADMA Investor Alert: ADMA Biologics Securities Fraud - GlobeNewswire
Rosen Law Firm Encourages ADMA Biologics, Inc. Investors to Inquire About Securities Class Action InvestigationADMA - Sahm
Adma Biologics (ADMA) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
ADMA Biologics (NASDAQ: ADMA) details 2026 virtual meeting, director elections and pay vote - Stock Titan
ADMA Biologics (ADMA) soars 11.6% as firm denies short seller allegations - MSN
ADMA Biologics, Inc. (ADMA) Crashes 16% Amid Scrutiny Over Skyrocketing Days Sales Outstanding That Short Seller Claims Points to Improper Channel Stuffing, Hagens Berman Investigating - PR Newswire
Technical Reactions to ADMA Trends in Macro Strategies - Stock Traders Daily
ADMA Biologics, Inc. (ADMA) Jumps 7.6% to $10.44 - AlphaStreet
ADMA Biologics Price Target Cut to $24.00/Share From $30.00 by Mizuho - Moomoo
Aug Mood: Can ADMA Biologics Inc outperform in the next rally2026 Weekly Recap & Weekly High Potential Stock Alerts - baoquankhu1.vn
ADMA Biologics Inc (NASDAQ:ADMA) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
ADMA Maintains Outperform Rating by Mizuho -- Price Target Lowered to $24 - GuruFocus
ADMA Biologics (NASDAQ:ADMA) Stock Price Up 7.6%Should You Buy? - MarketBeat
Risk Check: Why is ADMA Biologics Inc stock going up2026 Sentiment & Detailed Earnings Play Alerts - baoquankhu1.vn
ADMA Biologics Investigated for Alleged Securities Fraud - National Today
$ADMA Investigation Reminder: ADMA Biologics Investors are - GlobeNewswire
ADMA Biologics gains after refuting short seller claims - MSN
Cantor Fitzgerald Downgrades ADMA Biologics (ADMA) to Neutral, Here’s Why - Insider Monkey
EV Market: Why is ADMA Biologics Inc stock going upBull Run & Momentum Based Trading Ideas - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Encourages ADMA Biologics, Inc. (ADMA) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Gap Down: Is ADMA Biologics Inc subject to activist investor interestStock Surge & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
ADMA Biologics (NASDAQ: ADMA) Investigated for Potential Federal Securities Laws Violations – Lowey Dannenberg, P.C. - Toronto Star
Is ADMA Poised for Margin Growth and Supply Expansion in 2026? - TradingView — Track All Markets
A Look At ADMA Biologics (ADMA) Valuation After Short Seller Allegations And Legal Investigations - Sahm
ADMA Biologics Faces Securities Fraud Probe Over Channel Stuffing Claims - National Today
ADMA Biologics Faces Securities Fraud Investigation Over Alleged Channel Stuffing - National Today
ADMA News Today | Why did ADMA Biologics stock go up today? - MarketBeat
Growth Value: Whats the fair value of ADMA Biologics Inc stock2026 Recap & Accurate Intraday Trade Tips - baoquankhu1.vn
Growth Value: Is ADMA Biologics Inc attractive for institutional investors2026 Price Swings & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Adma Biologics (ADMA) Laps the Stock Market: Here's Why - Yahoo Finance
ADMA Fraud Notice: ADMA Biologics Investors are Notified the Company is being Investigated for Securities Fraud after 29% Stock Drop — BFA Law - Business Wire
Advantage Alpha Capital Partners LP's ADMA Biologics Inc(ADMA) Holding History - GuruFocus
Bragar Eagel & Squire, P.C. Urges ADMA Biologics, Inc. - GlobeNewswire
Bragar Eagel & Squire, P.C. Urges ADMA Biologics, Inc. (NASDAQ:ADMA) Investors to Contact the Firm Regarding Ongoing Investigation - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ADMA Biologics, Inc. (ADMA) And Encourages Shareholders to Reach Out - ACCESS Newswire
ADMA Technical Analysis & Stock Price Forecast - Intellectia AI
Lowey Dannenberg, P.C. is Investigating ADMA Biologics (NASDAQ: ADMA) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm - The Globe and Mail
Lowey Dannenberg, P.C. is Investigating ADMA Biologics - GlobeNewswire
ADMA Investor Announcement: ADMA Biologics Investigated - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ADMA Biologics, Inc. (ADMA) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
ADMA Biologics Under Investigation for Securities Violations - Intellectia AI
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA ... - Bluefield Daily Telegraph
ADMA Biologics: The Short Report Is The Noise, Not The Signal (NASDAQ:ADMA) - Seeking Alpha
Aberdeen Group Reduces ADMA Biologics Stake - National Today
ADMA Biologics Inc $ADMA Stock Holdings Lessened by Aberdeen Group plc - MarketBeat
ADMA INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving ADMA Biologics, Inc. - ACCESS Newswire
Will Securities Probes Into Alleged Channel Stuffing Change ADMA Biologics' (ADMA) Narrative? - Sahm
ADMA stock downgraded by Cantor as ‘channel stuffing’ claims shake investor confidence - MSN
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ADMA Biologics, Inc. (ADMA) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
ADMA Biologics, Inc. (ADMA) Crashes 16% Amid Scrutiny Over - GlobeNewswire
Shareholder News: ADMA Biologics (NASDAQ:ADMA) Drops 29% - GlobeNewswire
Allspring Global Investments Holdings LLC Decreases Stock Position in ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics slams short seller claims, highlights strong demand - MSN
ADMA Biologics extends selloff as Cantor downgrades after short report - MSN
ADMA Biologics, Inc. (ADMA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
0.45%
0.77%
자본화:
|
볼륨(24시간):